Skip to main content
. 2017 Aug 10;9(1):555–562. doi: 10.1080/21505594.2017.1356503

Table 2.

The Main Pharameters after Oral Administration of Ost-suspension and Ost-S100-NPs in rats. Mean ± SE (n = 8).

Parameters
Units
Ost-suspension
Ost-S100-NP
Cmax μg·ml−1 1.87 ± 0.24 3.15 ± 0.29**
Tpeak h 2.25 ± 0.21 4.21 ± 0.25**
ka h−1 1.25 ± 0.16 0.44 ± 0.09**
k10 h−1 0.43 ± 0.02 0.45 ± 0.02*
AUC μg·h·ml−1 55.47 ± 3.33 93.58 ± 4.85**
CL mg·kg−1·h−1/ μg·ml−1 0.45 ± 0.02 0.27 ± 0.01**
MRT h 22.10 ± 0.87 23.48 ± 0.64**
Fr(%)   168.7%

Notes.

*

P < 0.05 vs. Ost-suspension;

**

P < 0.01 vs. Ost-suspension.

Cmax: maximum concentration; Tpeak: time to reach Cmax; ka: the absorption constant from gastrointestinal tract to central compartment; k10: elimination constant of the central compartment; AUC:area under concentration curve; CL: clearance; MRT: mean retention time; Relative bioavailability: Fr % = ( AUCOst-S100-NP / AUCOst-suspension) × 100%